Science & Research

The head of UCLA’s Semel Institute for Neuroscience and Human Behavior is aiming to convert the institute’s top floor into a rooftop garden, or “living laboratory,” designed to study and facilitate psychedelic-assisted therapy.

The National Institutes of Standards and Technology is selling reference materials to help testing labs and law enforcement agencies accurately measure key components in cannabis products and better distinguish between hemp and THC-rich cannabis products.

British researchers investigating the efficacy of medical cannabis for older patients said that people aged 65+ who are prescribed medical cannabis report experiencing “significant improvements across all measures of well-being.”

Researchers at the Washington University School of Medicine in St. Louis recently reported findings that link cannabis use to an increased risk of severe illness related to COVID-19.

Researchers analyzing data from the Midlife in the United States (MIDUS) study recently found that older adults who have used psychedelics tend to exhibit better cognitive function and fewer depressive symptoms.

In a review of the hallucinogen MDMA posted last week, the FDA highlighted concerns about the initial investigations into the drug as a potential new therapy for the treatment of post-traumatic stress disorder (PTSD).

A recent study found that terpenes could be an effective and side-effect-free treatment for chemotherapy-induced neuropathic pain.

Recent research suggests that despite the popular stereotype, people who regularly consume cannabis are not more lazy or unmotivated than non-consumers.

A recent study found that non-medical cannabis use is “significantly associated with 96% decreased odds” of experiencing cognitive decline in adults aged 45 and older.

Researchers from Health Canada and the National Research Council of Canada reported finding metal nanoparticles inside both legally and illegally sourced cannabis vape pen liquids.

A recent study published in JAMA reveals that 11.4% of U.S. 12th graders reported using delta-8 THC in the past year, with usage patterns varying by region and state cannabis laws, highlighting concerns over the regulatory oversight of this emerging cannabinoid.

Many of California’s cannabis testing labs are currently not allowed to test the potency of flower products due to a rule change designed to combat so-called “lab shopping” in the state.

Researchers with the Johns Hopkins University School of Medicine, with the support of a $10 million federal grant, are set to track 10,000 U.S. cannabis patients from the start of their medical cannabis journey through at least a year to better understand the efficacy and effects of cannabis medicine.